Clinical Scorecard: Interventional Valve-Enhancing Trabeculotomy
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Enhances physiologic outflow through Schlemm's canal by cleaving the trabecular meshwork while preserving valve function. |
| Target Population | Patients with moderate to advanced open-angle glaucoma. |
| Care Setting | Ophthalmic surgical settings. |
Key Highlights
- Minimally invasive approach to glaucoma surgery.
- Designed to preserve intracanalicular structures and enhance pulsatile outflow.
- Statistically significant reduction in intraocular pressure (IOP) observed.
- Reduction in glaucoma medication usage post-surgery.
- Utilizes specialized microspatulas for precise incisions.
Guideline-Based Recommendations
Diagnosis
- Assess intraocular pressure and evaluate the severity of glaucoma.
Management
- Consider iVEnT for patients with moderate to advanced glaucoma who require surgical intervention.
Monitoring & Follow-up
- Regularly monitor IOP and medication usage postoperatively.
Risks
- Potential for scarring and complications related to incision depth and angle.
Patient & Prescribing Data
Patients with moderate to advanced open-angle glaucoma.
iVEnT has shown a reduction in IOP from 16.2 mmHg to 13.5 mmHg at 6 months and 13.4 mmHg at 24 months.
Clinical Best Practices
- Utilize gonioscopic visualization during the procedure.
- Ensure precision in incision placement to minimize trauma.
- Adapt techniques from GATT for effective outcomes.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
